Unrelated cord blood transplantation: Outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies

Transplantation

Volumn 95, Issue 10, 2013, Pages 1284-1291

  Rocha, Vanderson ^a,b,c   Labopin, Myriam ^d   Ruggeri, Annalisa ^a,b,e   Podestà, Marina ^f   Gallamini, Andrea ^g   Bonifazi, Francesca ^h   Sanchez Guijo, Fermin M ⁱ   Rovira, Montserrat ^j   Socie, Gerard ^a   Baltadakis, Ioannis ^k   Michallet, Mauricette ^l   Deconinck, Eric ^m   Bacigalupo, Andrea ⁿ   Mohty, Mohamad ^o   Gluckman, Eliane ^a,b   Frassoni, Francesco ^f  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d HÔPITAL SAINT ANTOINE   (France)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f G GASLINI INSTITUTE   (Italy)

^g Ospedale di Cuneo   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^j HOSPITAL CLÍNIC   (Spain)

^k EVANGELISMOS HOSPITAL   (Greece)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁿ UNIVERSITY OF GENOA   (Italy)

^o NANTES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Double cord blood transplantation; Myeloablative conditioning regimen; Single unit intrabone injection

Indexed keywords

BUSULFAN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DOUBLE UNIT INTRAVENOUS INJECTION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONMYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE UNIT INTRABONE INJECTION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES;

EID: 84878565083     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318288ca4d     Document Type: Article

References (35)

1. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276.
2. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265.
3. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653.
4. Rocha V, Broxmeyer HE. New approaches for improving engraftment after cord blood transplantation. Biol Blood Marrow Transplant 2009; 16(1 Suppl): S126.
5. Brunstein CG, Gutman JA, Weisdorf DJ, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010; 116: 4693.
6. Barker JN,Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343.
7. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064.
8. Ballen KK, Spitzer TR, Yeap BY, et al. Double unrelated reducedintensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007; 13: 82.
9. Frassoni F, Gualandi F, Podesta M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008; 9: 831.
10. van Hennik PB, De Koning AE, Ploemacher RE. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999; 94: 3055.
11. Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantationrelated factors. Br J Haematol 2009; 147: 262.
12. Iori AP, Cerretti R, De Felice L, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant 2004; 33: 1097.
13. Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011; 117: 3277.
14. Delaney C, Heimfeld S, Brashem-Stein C, et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16: 232.
15. Rocha V, Crotta A, Ruggeri A, et al. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract Res Clin Haematol 2010; 23: 223.
16. Ramirez P, Wagner JE, Defor TE, et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant 2012; 47: 799.
17. Van Agthoven M, Groot MT, Verdonck LF, et al. Cost analysis of HLAidentical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukemia. Bone Marrow Transplantation 2002; 30: 243.
18. Castello S, PodestaM,Menditto VG, et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol 2004; 32: 782.
19. Baba S, Inaba M, Iwai H, et al. Intra-bone marrowYbone marrow transplantation facilitates hemopoietic recovery including dendritic cells. Immunobiology 2005; 210: 33.
20. Massollo M, Podesta M, Marini C, et al. Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. Exp Hematol 2010; 38: 968.
21. Ha?gglund H, Ringde'n O, Agren B, et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant 1998; 21: 331.
22. MacMillan ML, Weisdorf DJ, Brunstein CG, et al. Acute graft-versushost disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410.
23. Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009; 114: 4293.
24. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000; 343: 1020.
25. El-Badri NS, Wang BY, Cherry, et al. Osteoblasts promote engraftment of allogeneic haematopoietic stem cells. Exp Hematol 1998; 26: 110.
26. Bartholomew A, Sturgeon C, Siatskas M, et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42.
27. Frassoni F, Labopin M, Bacigalupo A, et al. Expanded mesenchymal stem cells (MSC), co-infused with HLA identical haematopoietic stem cell transplants, reduce acute and chronic graft-versus-host disease: a matched pair analysis. Bone Marrow Transplant 2002; 29(Suppl 2): S2.
28. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439.
29. Fukui J, Inaba M,Ueda Y, et al. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells. Stem Cells 2007; 25: 1595.
30. Ramirez P, Brunstein CG, Miller B, et al. Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival. Bone Marrow Transplant 2011; 46: 981.
31. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLAidentical siblings. J Clin Oncol 1997; 15: 1767.
32. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol 2006; 18: 571.
33. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graftversus- host disease in human recipients of marrow from HLAmatched sibling donors. Transplantation 1974; 18: 295.
34. Cox DR. Regression model and life tables. J R Stat Soc B 1972; 34: 187.
35. Fine JP, Gray R. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496.